Wyeth, Inc. (WYE1)

Sector:
HEALTH CARE
Industry:
BIOTECHNOLOGY & LIFE SCIENCES
SIC:
PHARMACEUTICAL PREPARATIONS
CEO:
Employees:
5 GIRALDA FARMS, MADISON, NJ 07940
9736605000

*** This stock is shown as delisted in our database. *** If you think this isn't correct then please let us know

N/A

View SEC Filings from WYE1 instead.

View recent insider trading info

Funds Holding WYE1 (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding WYE1 BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

TORELL JOHN R III

  • Director
No longer subject to file 2009-10-15 0

MASCOTTE JOHN P

  • Director
No longer subject to file 2009-10-15 0

COST TIMOTHY SR. VP- CORPORATE AFFAIRS

  • Officer
No longer subject to file 2009-10-15 0

MAHADY JOSEPH M SR. VP & PRES., WYETH PHARMA.

  • Officer
No longer subject to file 2009-10-15 0

STEIN LAWRENCE V SR. VP AND GENERAL COUNSEL

  • Officer
No longer subject to file 2009-10-15 0

POLAN MARY LAKE PH D

  • Director
No longer subject to file 2009-10-15 0

POUSSOT BERNARD J CHAIRMAN, PRESIDENT AND CEO

  • Officer
  • Director
No longer subject to file 2009-10-15 0

CRITELLI MICHAEL J

  • Director
No longer subject to file 2009-10-15 0

AMEN ROBERT M

  • Director
No longer subject to file 2009-10-15 0

GANZI VICTOR F

  • Director
No longer subject to file 2009-10-15 0

ROGERS GARY L

  • Director
No longer subject to file 2009-10-15 0

LANGER ROBERT

  • Director
No longer subject to file 2009-10-15 0

FERGUSSON FRANCES D

  • Director
No longer subject to file 2009-10-15 0

HOFSTAETTER THOMAS SR. VP- CORP. BUS. DEV.

  • Officer
No longer subject to file 2009-10-15 0

PORTWOOD CHARLES A EXEC. VP TO&PS

  • Officer
No longer subject to file 2009-10-15 0

WOLD MARY KATHERINE SR. VP- FINANCE

  • Officer
No longer subject to file 2009-10-15 0

MCGUIRE RAYMOND J

  • Director
No longer subject to file 2009-10-15 0

NORDEN GREGORY SR. VP AND CFO

  • Officer
No longer subject to file 2009-10-15 0

REDMOND CAVAN M. PRES., WCH & FDAH

  • Officer
No longer subject to file 2009-10-15 0

PEPPARD DENISE M. SR. VP HUMAN RESOURCES

  • Officer
No longer subject to file 2009-10-15 0

DELUCA RICHARD R. PRES. FORT DODGE ANIMAL HEALTH

  • Officer
No longer subject to file 2009-10-15 0

GERMANO GENO J PRES.-US PHARM. & WOM. HEALTH.

  • Officer
No longer subject to file 2009-10-15 0

KELLY JOHN C. VP AND CONTROLLER

  • Officer
No longer subject to file 2009-10-15 0

DOLSTEN MIKAEL SR. VP & PRES., WYETH RESEARCH

  • Officer
No longer subject to file 2009-10-15 0

KREBS ANDREAS PRESIDENT, EMEA & CANADA

  • Officer
No longer subject to file 2009-10-15 0

KAMARCK MICHAEL E. PRESIDENT, TO&PS

  • Officer
No longer subject to file 2009-10-15 0

WIINBERG ULF SR. VP&PRES. WYETH PHARM EMEA

  • Officer
71,499 2008-04-25 0

ESSNER ROBERT CHAIRMAN OF THE BOARD

  • Officer
  • Director
0 2008-04-24 0

FEERICK JOHN D

  • Director
11,043 2008-04-24 0

RUFFOLO ROBERT R SENIOR VP

  • Officer
242,696 2007-11-17 0

LEWIN RENE R SR. VP- HUMAN RESOURCES

  • Officer
76,108 2007-10-26 0

RHUDY MARILY H SR. VP PUBLIC AFFAIRS

  • Officer
25,960 2007-10-24 0

SEIDENBERG IVAN G

  • Director
19,445 2007-10-15 0

SHIPLEY WALTER V

  • Director
12,237 2007-10-15 0

MARTIN KENNETH J CFO AND VICE CHAIRMAN

  • Officer
257,129 2007-06-13 0

ROGERS DOUGLAS A PRES., WYETH CONSUMER HEALTH.

  • Officer
15,743 2007-05-22 0

JONES PAUL J VP AND CONTROLLER

  • Officer
91,223 2007-05-01 0

CORCORAN E THOMAS PRES. FORT DODGE ANIMAL HEALTH

  • Officer
38,070 2007-04-26 0

CARRION RICHARD L

  • Director
9,544 2006-04-17 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
No current insider transactions

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin

Elevate your investments